The group’s principle activities include discovering, developing and marketing new therapies. The group products include Etimicin Sulfate, 5-Deoxy-Fluorordine. Vasostatin Apo2L, Apoptotic Factor rh-Apo2l, and Anti-CD86. The group marketed its products under the trade names Aida, AiYi, ChuangCheng, and PanRou. The group operates from China and the United States.
